Author： Elhayany Asher Mishaal Ram Avraham Vinker Shlomo
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.11, Iss.2, 2012-03, pp. : 185-190
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Statins may benefit patients with high levels of C-reactive protein
Inpharma, Vol. 1, Iss. 1323, 2002-01 ,pp. :
Access to resources
Recommend
Patients with acute myocardial infarction (MI) benefit from early treatment with statins
Inpharma, Vol. 1, Iss. 1289, 2001-01 ,pp. :
ATP III update targets high-risk patients, statins market to benefit?
Inpharma, Vol. 1, Iss. 1447, 2004-01 ,pp. :
ATP III update targets high-risk patients, statins market to benefit?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 458, 2004-01 ,pp. :